東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Gene Function." ]

切換: 標籤 | MARC模式 | ISBD

Progranulin and central nervous syst...

Hara, Hideaki.

FindBook

Google Book

Amazon

博客來

Progranulin and central nervous system disorders

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Progranulin and central nervous system disorders/ edited by Hideaki Hara ... [et al.].
其他作者:	Hara, Hideaki.
出版者:	Singapore :Springer Singapore : : 2019.,
面頁冊數:	vii, 183 p. :ill., digital ;24 cm.
內容註:	Chapter 1. Molecular and Functional Properties of Progranulin -- Chapter 2. Progranulin as a biomarker for neurodegenerative diseases -- Chapter 3. PGRN and FTLD -- Chapter 4. PGRN and neurodegenerative diseases other than FTLD -- Chapter 5. Progranulin Regulations of Lysosomal Homeostasis and its Involvement in Neurodegenerative Diseases -- Chapter 6. Molecular and Functional Properties of Progranulin -- Chapter 7. PGRN and neuroinflammation -- Chapter 8. Neural Stem/Progenitor Cells and Progranulin -- Chapter 9. Generation and phenotyping of progranulin-deficient mice -- Chapter 10. Pleiotropic protective effects of progranulin in the treatment of ischemic stroke -- Chapter 11. New therapeutic approaches against ocular diseases.
Contained By:	Springer eBooks
標題:	Proteins. -
電子資源:	https://doi.org/10.1007/978-981-13-6186-9
ISBN:	9789811361869

Progranulin and central nervous system disorders
Progranulin and central nervous system disorders[electronic resource] /edited by Hideaki Hara ... [et al.]. - Singapore :Springer Singapore :2019. - vii, 183 p. :ill., digital ;24 cm.

Chapter 1. Molecular and Functional Properties of Progranulin -- Chapter 2. Progranulin as a biomarker for neurodegenerative diseases -- Chapter 3. PGRN and FTLD -- Chapter 4. PGRN and neurodegenerative diseases other than FTLD -- Chapter 5. Progranulin Regulations of Lysosomal Homeostasis and its Involvement in Neurodegenerative Diseases -- Chapter 6. Molecular and Functional Properties of Progranulin -- Chapter 7. PGRN and neuroinflammation -- Chapter 8. Neural Stem/Progenitor Cells and Progranulin -- Chapter 9. Generation and phenotyping of progranulin-deficient mice -- Chapter 10. Pleiotropic protective effects of progranulin in the treatment of ischemic stroke -- Chapter 11. New therapeutic approaches against ocular diseases.

This book presents the latest knowledge on the roles of progranulin (PGRN) in normal physiology and pathology and explores the emerging significance of PGRN as a therapeutic target and biomarker in various CNS disorders, including frontotemporal lobe degeneration and other neurodegenerative diseases. Following initial recognition of the importance of PGRN in sexual differentiation of the developing brain and adult neurogenesis, it was subsequently discovered that PGRN acts as a chaperone of lysosomal enzymes and plays a crucial role in maintaining cellular protein homeostasis. It has also been found that sex steroids modulate the expression of PGRN and its trophic effects in the developing CNS and that PGRN directly or indirectly influences neural stem and progenitor cells. Against this background, deeper understanding of the molecular and functional properties of PGRN would provide fresh impetus for the development of mechanism-based therapeutic approaches for multiple disorders. Medications targeting the recovery of lysosomal function appear to hold particular promise in patients with neurodegenerative diseases resulting from PGRN insufficiency. In examining multiple aspects of this fascinating field, the book will be of high value for researchers and graduate students.

ISBN: 9789811361869

Standard No.: 10.1007/978-981-13-6186-9doiSubjects--Topical Terms:

558769
Proteins.

LC Class. No.: QP552.G59

Dewey Class. No.: 572.6

Progranulin and central nervous system disorders
LDR:03013nmm a2200325 a 4500 001 2180217
003 DE-He213
005 20190325055806.0
006 m d
007 cr nn 008maaau
008 191122s2019 si s 0 eng d
020 $a 9789811361869 $q (electronic bk.)
020 $a 9789811361852 $q (paper)
024 7 $a 10.1007/978-981-13-6186-9 $2 doi
035 $a 978-981-13-6186-9
040 $a GP $c GP
041 0 $a eng
050 4 $a QP552.G59
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
072 7 $a MFN $2 thema
082 0 4 $a 572.6 $2 23
090 $a QP552.G59 $b P964 2019
245 0 0 $a Progranulin and central nervous system disorders $h [electronic resource] / $c edited by Hideaki Hara ... [et al.].
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a vii, 183 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Molecular and Functional Properties of Progranulin -- Chapter 2. Progranulin as a biomarker for neurodegenerative diseases -- Chapter 3. PGRN and FTLD -- Chapter 4. PGRN and neurodegenerative diseases other than FTLD -- Chapter 5. Progranulin Regulations of Lysosomal Homeostasis and its Involvement in Neurodegenerative Diseases -- Chapter 6. Molecular and Functional Properties of Progranulin -- Chapter 7. PGRN and neuroinflammation -- Chapter 8. Neural Stem/Progenitor Cells and Progranulin -- Chapter 9. Generation and phenotyping of progranulin-deficient mice -- Chapter 10. Pleiotropic protective effects of progranulin in the treatment of ischemic stroke -- Chapter 11. New therapeutic approaches against ocular diseases.
520 $a This book presents the latest knowledge on the roles of progranulin (PGRN) in normal physiology and pathology and explores the emerging significance of PGRN as a therapeutic target and biomarker in various CNS disorders, including frontotemporal lobe degeneration and other neurodegenerative diseases. Following initial recognition of the importance of PGRN in sexual differentiation of the developing brain and adult neurogenesis, it was subsequently discovered that PGRN acts as a chaperone of lysosomal enzymes and plays a crucial role in maintaining cellular protein homeostasis. It has also been found that sex steroids modulate the expression of PGRN and its trophic effects in the developing CNS and that PGRN directly or indirectly influences neural stem and progenitor cells. Against this background, deeper understanding of the molecular and functional properties of PGRN would provide fresh impetus for the development of mechanism-based therapeutic approaches for multiple disorders. Medications targeting the recovery of lysosomal function appear to hold particular promise in patients with neurodegenerative diseases resulting from PGRN insufficiency. In examining multiple aspects of this fascinating field, the book will be of high value for researchers and graduate students.
650 0 $a Proteins. $3 558769
650 0 $a Glycoproteins. $3 667972
650 0 $a Neurogenetics. $3 656076
650 1 4 $a Gene Function. $3 1067308
650 2 4 $a Molecular Medicine. $3 890952
650 2 4 $a Protein Science. $3 1067276
650 2 4 $a Neurosciences. $3 588700
700 1 $a Hara, Hideaki. $3 3386091
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-13-6186-9
950 $a Biomedical and Life Sciences (Springer-11642)